YOU ARE HERE:
WHO: we are still on track for 3 x 5 HIV treatment goal
Despite pessimistic warnings from critics last week, the World Health Organisation announced yesterday that it is only 60,000 short of its July 2004 target for getting people onto treatment.
“Our milestone for July 2004 was 500,000, we have reached 440,000, which is a 50% increase since Barcelona and only 60,000 short of the milestone,” said Dr Jim Yoong Kim of the World Health Organisation at a meeting to review progress on the 3 x 5 target on the opening day of the Fifteenth International AIDS Conference in Bangkok.
Dr Kim said that WHO had expected the scale up of treatment to escalate slowly at first, but that 56 countries have now asked for assistance in developing national treatment scale-up plans.
He also admitted that cash had been a huge problem in moving forward, but, “the extraordinary generosity of Canada enabled us to move forward.”
On Friday outgoing International AIDS Society, Dr Joep Lange, president criticised WHO for setting the 3 x 5 target, saying that more attention needed to be paid to building health systems and treatment projects from the ground up before going to a larger scale.
Dr Kim responded that “the core business of WHO is disease prevention and building health systems. We think that pushing for 3 x 5 is the way to build up prevention and build health systems.”
He went on: “3 x 5 is the only morally defensible target. I wake up every morning in a cold sweat thinking about what a big target we’ve set and how little time we have, and the only solace is that I know that how people waiting for the drugs must feel too.”
“Our milestone for July 2004 was 500,000, we have reached 440,000, which is a 50% increase since Barcelona and only 60,000 short of the milestone,” said Dr Jim Yoong Kim of the World Health Organisation at a meeting to review progress on the 3 x 5 target on the opening day of the Fifteenth International AIDS Conference in Bangkok.
Dr Kim said that WHO had expected the scale up of treatment to escalate slowly at first, but that 56 countries have now asked for assistance in developing national treatment scale-up plans.
He also admitted that cash had been a huge problem in moving forward, but, “the extraordinary generosity of Canada enabled us to move forward.”
On Friday outgoing International AIDS Society, Dr Joep Lange, president criticised WHO for setting the 3 x 5 target, saying that more attention needed to be paid to building health systems and treatment projects from the ground up before going to a larger scale.
Dr Kim responded that “the core business of WHO is disease prevention and building health systems. We think that pushing for 3 x 5 is the way to build up prevention and build health systems.”
He went on: “3 x 5 is the only morally defensible target. I wake up every morning in a cold sweat thinking about what a big target we’ve set and how little time we have, and the only solace is that I know that how people waiting for the drugs must feel too.”
aidsmap resources
Africa news
- The Lancet: HIV is a global disaster
- Most HIV infections in Zambia and Rwanda happen in marriage: prevention programmes for couples recommended
- Fourteen-week nevirapine prophylaxis for infants reduces postnatal HIV infection
Asia and Pacific news
- Anti-HIV treatment provided to 3 million in poorer countries by end of 2007
- Rapid HIV testing of women in labour in rural India feasible
- Regular CD4 monitoring, big rise in HIV diagnosis, key to reducing AIDS death rate
Conference news
- Activists arrested during attempt to highlight Uganda's neglect of HIV prevention for men who have sex with men
- Malaria returns when Ugandan ART patients stop cotrimoxazole
- Impaired kidney function present in quarter of Zambians starting ART
Eastern Europe and Russia news
- Anti-HIV treatment provided to 3 million in poorer countries by end of 2007
- 2010 International AIDS Conference set for Vienna, with Eastern Europe focus
- Estudo Russo revela mudança de comportamentos de risco entre os utilizadores de droga mais jovens
Latin America news
- High death rates in Peruvian patients defaulting from multi-drug-resistant tuberculosis treatment
- Anti-HIV treatment provided to 3 million in poorer countries by end of 2007
- Some HIV subtypes may carry natural resistance to tipranavir
Middle East news
- Half of all new HIV infections could be averted if proven prevention efforts expanded
- Roche agrees to temporary suspension of nelfinavir's (Viracept) European license - updated
- WHO/UNAIDS endorse opt-out HIV testing
